Overview:
Alopecia, or excessive hair loss (baldness) is common in many men and some women in midlife. This condition may have significant psychological and emotional repercussions. The most effective treatment for alopecia depends on the inherent cause of the condition. The various causes of occurrence of alopecia in men and women are hormonal changes, heredity, stress, pollution, side effects of any medical treatment, dietary habits and chemicals. The prevalence of alopecia is high in middle-age population, whereas preference for treatment is higher in developed regions of the world. However, in the past few years, the demand for clinical treatments of alopecia is on a steep rise in the developing countries in South Asia, Middle East and Latin America.
Hair transplantation is most commonly opted for alopecia treatment. Follicular unit transplant is the most common mode of hair transplant preferred by both patients and trichologists. Males form the largest consumers of hair loss treatments. However, women form a huge customer base for over the counter solutions. Growing disposable incomes, rising celebrity culture and growing awareness about the available treatment options and their efficacy and safety are some of the prime factors that drive the global alopecia treatment market. Further intensive research activities towards introducing innovative treatment options and growth in disposable incomes of the general population will allow significant growth of this market.
The global alopecia treatment market is segmented on the following bases:
1. Treatment Type
a. Topical
b. Systemic
c. Others
2. Gender
a. Males
b. Females
3. Geography
- North America
- Europe
- Germany
- France
- Italy
- U.K.
- Russia
- Rest of Europe
- Asia-Pacific
- India
- China
- Japan
- Rest of Asia-Pacific
- Latin America
- Brazil
- Mexico
- Rest of Latin America
- Middle East and Africa
- GCC Countries
- South Africa
- Rest of Middle East and Africa
Key players identified for alopecia treatment market include but are not limited to:
Johnson & Johnson, Dr. Reddy’s Laboratories, Alpecin, Merck & Co., Phyto – Alès Groupe, Vitabiotics, Viviscal, Cipla and several others
This report offers:
- An overview of the global markets for alopecia treatment
- Market trends assessment for the period 2014-2022, with historical information for 2014 & 2015, and projections through 2022, with respective CAGRS during 2016-2022
- Qualitative assessment tools such as market drivers, challenges and future prospects, major commercial events, etc.
- Market competition scrutiny tools such as market share analysis, major market events assessment and attractive investment proposition
- Focus on each level of market segmentation based on product approvals, launch, and current and anticipated market dynamics
- A general overview of the industry structure
- Company profiles highlighting key information about the major players operating in the alopecia treatment market
